ChemicalBook Chinese Germany Japanese Korean

凯试(上海)科技有限公司 Company Information

Company Name:    Chemsky(shanghai)International Co.,Ltd.
Tel:    021-50135380
Fax:   
Email:    shchemsky@sina.com
Nationality:    China
WebSite:    www.shchemsky.com
Product List:    32360
306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324

Product List
Cys-Trp-Arg-Nva-Arg-Tyr-NH2 (DiMerized through Cys31-Cys31');[Cys31, Trp32, Nva34]Neuropeptide Y (31-36);Bis (31/31)
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6);[Arg8]Vasotocin 113-80-4
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (Disulfide bridge Cys1-Cys6);Oxytocin 50-56-6
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2 (Disulfide bridge Cys1-Cys6);[Thr4, Gly7]Oxytocin 60786-59-6
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6);[Arg8]Vasopressin 113-79-1
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge Cys1-Cys6);[Lys8]Vasopressin 50-57-7
Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp (Disulfide bridge Cys11-Cys15);IRL1038;[Cys11, Cys15]Endothelin-I (11-21) 144602-02-8
D-Ala-D-Nal(2)-Ala-Trp-D-Phe-Lys-NH2 acetate salt;GHRP-2 158861-67-7
D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg;[D-Arg0, Hyp3, D-Phe7, Leu8]Bradykinin 135701-67-6
D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg;[D-Arg0, Hyp3, Thi5,8, D-Phe7]Bradykinin 103412-42-6
D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic;[Des-Arg10]HOE 140 130308-48-4
D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg;HOE 140 138614-30-9
D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2;[D-Arg1, D-Pro2, D-Trp7,9, Leu11]Substance P 84676-91-5
D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2;[D-Arg1, D-Phe5, D-Trp7,9, Leu11]Substance P 96736-12-8
D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2;Spantide I;[D-Arg1, D-Trp7,9, Leu11]Substance P 91224-37-2
delta-aMinovaleryl-Phe-Phe-Pro-NMe-Leu-Met-NH2;GR73632;delta-aMinovaleryl-[Pro9, NMe-Leu10]Substance P (7-11) 133156-06-6
D-Lys(nicotinoyl)-Pro-3-(3-pyridyl)-Ala-Pro-3,4-dichloro-D-Phe-Asn-D-Trp-Phe-D-Trp-Leu-Nle-NH2;Spantide II
DMpc-gaMMa-MeLeu-D-Trp(1-CO2CH3)-D-Nle.Na (DMpc : cis-2,6-DiMethylpiperidinocarbonyl);BQ788 (sodiuM salt);DMpc-gaMMa-MeLeu-D-Trp(1-CO2CH3)-D-Nle.Na 156161-89-6
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7);[DOTA-DPhe1, Tyr3]Octreotide;Edotreotide 204318-14-9
Dpd. TFA salt;(+)-Deoxypyridinoline. TFA salt 83462-55-9
D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 (Disulfide bridge Cys2-Cys7);RC160 103222-11-3
D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (Disulfide bridge Cys2-Pen7);Cys2, Tyr3, Orn5, Pen7 aMide;Cys2, Tyr3, Orn5, Pen7 aMide - CTOP 103429-31-8
D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 (LactaM bridge Glu30-Lys33);[D-Phe12, Nle21,38, Glu30, Lys33]CRF (12-41), cyclic, lactaM, huMan, rat;Astressin 170809-51-5
D-Phe-Pip-Arg-pNA (Pippipecolyl);D-Phe-Pip-Arg-pNA 115388-96-0
D-RGDW;D-Arg-Gly-Asp-Trp
D-Ser-Arg-Val-Tyr-Ile-His-Pro-Phe;[D-Ser1]Angiotensin II, huMan
D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2;[D-Tyr27,36, D-Thr32]Neuropeptide Y (27-36) 163887-48-7
D-Val-Leu-Arg-pNA;D-Val-Leu-Arg-pNA 162303-66-4
epsilon-N-(2-furoyl-Methyl)-L-Lysine.2HCl;Furosine dihydrochloride 19746-33-9
epsilon-N-3-hydroxypropyl-L-Lysine. acetate
epsilon-N-carboxy(2H2)Methyl-L-Lysine;CML-d2
epsilon-N-carboxyethyl-L-[4,4,5,5-2H4]Lysine (Mixture of two diastereoisMers);CEL-d4
epsilon-N-carboxyethyl-L-Lysine (Mixture of two diastereoisoMers)
Fluorescein-Ahx-Gly-Ser-Ser(O-n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg (AhxAMinohexanoic acid);Fluo-Ghrelin, huMan
FR139317;(N,N-hexaMethylene) carbaMoyl-Leu-D-Trp(N-Me)-D-2-Pya 142375-60-8
Galanin (2-11), porcine, rat 367518-31-8
Gln-Ala-Gly-His-Asn-Lys-Val-Gly-Ser-Leu-Gln-Tyr-Leu;VIF (136-148) (2)
Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr;ODN-DBI, huMan;ODN-DiazepaM Binding Inhibitor, huMan (2)
Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys;ODN-DBI, rat;ODN-DiazepaM Binding Inhibitor, rat (2) 95237-86-8
Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys-Tyr;ODN-DBI-[Tyr19], rat;ODN-DiazepaM Binding Inhibitor-[Tyr19], rat (2)
Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe;GP120 (315-322) (2)
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala ((2) Due to the presence of a Gln in N-terMinal position this peptide can contain the pyroglutaMic forM);[Ala13]Apelin-13, huMan, bovine, Mouse, rat (F13A) (2) 568565-11-7
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe ((2) Due to the presence of a Gln in N-terMinal position this peptide can contain the pyroglutaMic forM);Apelin-13, huMan, bovine, Mouse, rat (2) 217082-58-1
Gln-Arg-Pro-Lys-Glu-Arg-His-Arg-Arg-Asn-Tyr-Val-Pro-Cys-His-Ile-Arg-Gln-Ile-Ile;GP140 (421-440) (1)(2)
Gln-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2;Pancreastatin (33-49), porcine (2) 106507-61-3
Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu;MBP (4-14);Myelin Basic Protein (4-14) (2) 126768-94-3
Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly;GP120 (427-436) (2)
Gln-Pro-Glu-Lys-Ala-Lys-Lys-Glu-Thr-Val-Glu-Lys-Ala-Val-Ala-Thr;TAT (110-125) (2)
Gln-Ser-Arg-Lys-Arg-Arg-Arg-Thr-Pro-Lys-Lys-Ala-Lys-Ala-Asn;TAT (78-92) (2)
Gln-Ser-Leu-Gly-Gly-Leu-Gly-Lys-Gly-Leu-Ser-Ser-Arg-Ser;NEF (41-54) (2)
Gln-Val-Pro-Leu-Arg-Pro-Met-Thr-Tyr-Lys;NEF (73-82) (2)
Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val;MART-1 (26-35), huMan (3) 156251-01-3
Glu-Ala-Asn-Lys-Gly-Glu-Asn-Asn-Cys-Leu-Leu-His-Pro-Met;NEF MN (157-170) (1) (3)
Glu-Ala-Asn-Lys-Gly-Glu-Asn-Thr-Ser-Leu-Leu-His-Pro-Val;NEF (155-168) (3)
Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr;MAGE-1 Antigen (161-169), huMan (3) 144449-86-5
Glu-Ala-Leu-Cys-Asp-Pro-Thr-Lys-Gly-Ser-Arg-Ser-Pro-Gln-Asp;REV (94-108) (1) (3)
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala;BINP;Brain Injury-derived Neurotrophic Peptide (3) 148330-12-5
Glu-Arg-Ala-Glu-Asp-Ser-Gly-Asn-Glu-Ser-Glu-Gly-Glu-Ile;VPU (47-60) (3)
Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr;DBI (42-50), huMan (3)
Glu-Asn-Asn-Cys-Leu-Leu-His-Pro-Met-Ser-Gln-His-Gly-Trp-Met;NEF MN (162-176) (1) (3)
Glu-Asn-Ile-Thr-Ala-Leu-Leu-Glu-Glu-Ala-Gln-Ile-Gln-Gln-Glu-Lys-Asn-Met-Tyr-Glu;GP140 (651-670) (3)
Glu-Asn-Phe-Ser-Gly-Gly-Cys-Val-Ala-Gly-Tyr-Met-Arg-Thr-Pro-Asp-Gly-Arg-Cys-Lys-Pro-Thr-Phe-Tyr-Gln (Disulfide bridge Cys7Cys19);Growth-blocking Peptide (3)
Glu-Asn-Thr-Ser-Leu-Leu-His-Pro-Val-Ser-Leu-His-Gly-Met-Asp;NEF (160-174) (3)
Glu-Asp-Cys-Gly-Thr-Ser-Gly-Thr-Gln-Gly-Val-Gly-Ser-Pro;REV (87-100) (1) (3)
Glu-Asp-Glu-Ala-Met-Ser-Ile-Thr-Ala;Arg-Arg-Lys-Asp-Leu-His-Asp-Asp-Glu-Glu-Asp-Glu-Ala-Met-Ser-Ile-Thr-Ala 154444-97-0
Glu-Asp-Leu-Leu-Lys-Ala-Val-Arg-Leu-Ile-Lys;REV (10-20) (3)
Glu-Gln-Ile-Gly-Trp-Met-Thr-Asn-Asn-Pro-Pro-Ile-Pro-Val-Gly-Glu-Ile;GAG P24 CA (113-129);P25 (245-261) (3)
Glu-Glu-Glu-Glu-Val-Gly-Phe-Pro-Val-Lys-Pro-Gln;NEF MN (64-75) (3)
Glu-Glu-Glu-Glu-Val-Gly-Phe-Pro-Val-Thr;NEF (62-71) (3)
Glu-Glu-Leu-Arg-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-Tyr;GAG P17 MA (73-86) (3);P18 (73-86)
Glu-Glu-Met-Leu-Phe-Ile-Tyr-Gly-His-Tyr-Lys-Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr;DBI (22-50), huMan
Glu-Gly-His-Ile-Ala-Arg-Asn-Cys-Arg-Ala-Pro-Arg-Lys-Lys-Gly;GAG P7 NC (21-35) (1) (3);P15 (398-412)
Glu-Gly-Ser-Asp-Thr-Ile-Thr-Leu-Pro-Cys-Arg-Ile-Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu;GP120 (414-434) (1) (3)
Glu-Gly-Thr-Asp-Arg-Val-Ile-Glu;GP41 (829-836) (3)
Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2;GLP-1 (9-36) aMide huMan 161748-29-4
Glu-Gly-Val-Tyr-Val-His-Pro-Val;Angiotensin II Antipeptide (3) 121379-63-3
Glu-His-Ile-Pro-Ala;Fibrinogen-Binding Peptide (3) 137235-80-4
Glu-His-Phe-Arg-Trp-Gly;ACTH (5-10), huMan
Glu-Ile-Cys-Thr-Glu-Met-Glu-Lys-Glu-Gly-Lys-Ile-Ser-Lys-Ile-Gly-Pro;RT (36-52) (1) (3);POL (203-219)
Glu-Ile-Gln-Lys-Gln-Gly-Gln-Gly-Gln-Trp-Thr-Tyr-Gln-Ile-Tyr-Gln-Glu-Pro-Phe-Lys-Asn-Leu-Lys-Thr-Gly;RT (328-352);POL (495-519) (3)
Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr;Fibronectin CS-1 Peptide (3) 136466-51-8
Glu-Ile-Leu-Ser-Gln-Leu-Tyr-Arg-Pro-Leu-Glu-Ala-Cys-Tyr;TAT (38-51) (1) (3)
Glu-Ile-Lys-Asp-Thr-Lys-Glu-Ala-Leu-Asp-Lys-Ile-Glu-Glu-Glu;GAG P17 MA (93-107) (3);P18 (93-107)
Glu-Leu-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val;MART-1 (26-35) (Leu27), huMan (3)
Glu-Leu-His-Pro-Glu-Tyr-Phe-Lys-Asn-Cys;NEF (197-206) (1) (3)
Glu-Leu-Thr-Tyr-Leu-Gln-Tyr-Gly-Trp-Ser-Tyr-Phe-His-Glu-Ala-Val-Gln-Ala-Gly-Trp;GP140 (821-840) (3)
Glu-Leu-Tyr-Lys-Tyr-Lys-Val-Val-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala;GP120 (487-502) (3)
Glu-Leu-Tyr-Lys-Tyr-Lys-Val-Val-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg;GP120 (487-509) (3)
Glu-Lys-Gly-Gly-Leu-Asp-Gly-Leu-Ile-Tyr-Ser-Gln-Lys-Arg;NEF MN (95-108) (3)
Glu-Lys-Gly-Gly-Leu-Glu-Gly-Ile-Tyr-Tyr-Ser-Ala-Arg-Arg;NEF (125-138) (3)
Glu-Lys-Gly-Gly-Leu-Glu-Gly-Leu-Ile-His-Ser-Gln-Arg-Arg;NEF (93-106) (3)
Glu-Pro-Trp-Lys-His-Pro-Gly-Ser-Gln-Pro-Lys-Thr;TAT (9-20)
Glu-Ser-Ala-Asn-Leu-Gly-Glu-Glu-Ile-Leu-Ser-Gln-Leu-Tyr-Arg;TAT (31-45) (3)
Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys;Endonuclease Antigenic Site (3)
Glu-Thr-Leu-Leu-Val-Gln-Asn-Ala-Asn-Pro-Asp-Cys-Lys-Thr-Ile-Leu-Lys-Ala-Leu;GAG P24 CA (187-205) (1) (3);P25 (319-337)
Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val (Disulfide bridge Cys5-Cys10);Urotensin II, huMan (3) 251293-28-4
Glu-Trp-Arg-Phe-Asp-Ser-Arg-Leu-Ala-Phe-His-His-Val-Ala-Arg-Glu-Leu;NEF (182-198) (3)
Glu-Trp-Glu-Arg-Lys-Val-Asp-Phe-Leu-Glu-Glu-Asn-Ile-Thr-Ala-Leu-Leu-Glu-Glu-Ala;GP140 (641-660) (3)
Glu-Tyr-Arg-Lys-Ile-Leu-Arg-Gln-Arg-Lys-Ile-Asp-Arg;VPU (28-40) (3)
Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr;MAGE-3.A1 (3)
306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324

Copyright 2007©  ChemicalBook. All rights reserved.